Travere Therapeutics Tech Stack

Travere Therapeutics uses 8 technology products and services including Linkedin Ads, SAS, Google Font API, and more. Explore Travere Therapeutics's tech stack below.

  • Linkedin Ads
    Advertising
  • SAS
    Business Intelligence
  • Google Font API
    Font Scripts
  • Modernizr
    Javascript Libraries
  • Webpack
    Miscellaneous
  • Agiloft
    Project Management
  • X-XSS-Protection
    Security
  • Adobe Creative Suite
    Visualisation Software

Media & News

Travere Therapeutics's Email Address Formats

Travere Therapeutics uses at least 4 format(s):
Travere Therapeutics Email FormatsExamplePercentage
first.middle@travere.comJohn.Michael@travere.com
33%
first.l@travere.comJohn.D@travere.com
34%
firlast@travere.comJohDoe@travere.com
22%
first@travere.comJohn@travere.com
11%

Frequently Asked Questions

Where is Travere Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Travere Therapeutics's main headquarters is located at 3611 Valley Centre Dr Suite 300 San Diego, California 92130 US. The company has employees across 2 continents, including North AmericaEurope.

What is Travere Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Travere Therapeutics is a publicly traded company; the company's stock symbol is TVTX.

What is Travere Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Travere Therapeutics's official website is travere.com and has social profiles on LinkedIn.

How much revenue does Travere Therapeutics generate?

Minus sign iconPlus sign icon
As of February 2024, Travere Therapeutics's annual revenue reached $35M.

What is Travere Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Travere Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Travere Therapeutics have currently?

Minus sign iconPlus sign icon
As of February 2024, Travere Therapeutics has approximately 390 employees across 2 continents, including North AmericaEurope. Key team members include Chief Business Officer: C. L.Chief Commercial Officer Cco: P. H.Chief Medical Officer: J. I.. Explore Travere Therapeutics's employee directory with LeadIQ.

What industry does Travere Therapeutics belong to?

Minus sign iconPlus sign icon
Travere Therapeutics operates in the Biotechnology Research industry.

What technology does Travere Therapeutics use?

Minus sign iconPlus sign icon
Travere Therapeutics's tech stack includes Linkedin AdsSASGoogle Font APIModernizrWebpackAgiloftX-XSS-ProtectionAdobe Creative Suite.

What is Travere Therapeutics's email format?

Minus sign iconPlus sign icon
Travere Therapeutics's email format typically follows the pattern of first.middle@travere.com. Find more Travere Therapeutics email formats with LeadIQ.

How much funding has Travere Therapeutics raised to date?

Minus sign iconPlus sign icon
As of February 2024, Travere Therapeutics has raised $200M in funding. The last funding round occurred on Feb 28, 2023.

When was Travere Therapeutics founded?

Minus sign iconPlus sign icon
Travere Therapeutics was founded in 2020.
Travere Therapeutics

Travere Therapeutics

Biotechnology ResearchCalifornia, United States201-500 Employees

Our mission is to identify, develop and deliver life-changing therapies to people living with rare disease. #InRareForLife 
Community Guidelines: https://travere.com/community-guidelines/

Section iconCompany Overview

Headquarters
3611 Valley Centre Dr Suite 300 San Diego, California 92130 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
TVTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
201-500

Section iconFunding & Financials

  • $200M

    Travere Therapeutics has raised a total of $200M of funding over 6 rounds. Their latest funding round was raised on Feb 28, 2023.

  • $10M$50M

    Travere Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $200M

    Travere Therapeutics has raised a total of $200M of funding over 6 rounds. Their latest funding round was raised on Feb 28, 2023.

  • $10M$50M

    Travere Therapeutics's revenue is in the range of $10M$50M

© LeadIQ, Inc. All rights reserved.